Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient

Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer's Patient Review Abstract Alzheimer's disease is often marked by progressive episodic memory loss, but not all patients start with an amnestic syndrome. Some patients may initially present with issues in visual-spatial skills, language, executive function,

Frontotemporal Dementia After the Bruce Willis Effect: What Neurologists Should Revisit

Frontotemporal Dementia After the Bruce Willis Effect What Neurologists Should Revisit Review Abstract The public disclosure of a frontotemporal dementia diagnosis by Bruce Willis brought unprecedented public attention to a neurodegenerative disorder that has historically remained underrecognized outside specialized neurology and memory clinics. While increased awareness has

Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing

Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing Review Abstract Lecanemab represents a major milestone in the treatment of Alzheimer’s disease as the first anti amyloid monoclonal antibody to receive traditional approval from the United States Food and Drug Administration for patients with early

Plasma Biomarkers for Neurodegenerative Disease: What Clinicians Need to Know in 2026

Plasma Biomarkers for Neurodegenerative Disease What Clinicians Need to Know in 2026 Review Key Takeaways Plasma biomarkers are rapidly transforming the diagnosis and management of Alzheimer’s disease and related dementias, representing one of the most notable advances in neurodegenerative medicine in recent decades. Historically, the definitive assessment of Alzheimer’s pathology has

How Deep Brain Stimulation Repairs Neural Pathways to End the Addiction Cycle

How Deep Brain Stimulation Repairs Neural Pathways to End the Addiction Cycle   Please like and subscribe if you enjoyed this video :-)     Introduction Drug addiction causes 11.8 million deaths each year, surpassing all cancer deaths combined. It has prompted experts to research other treatment modalities

Alzheimer’s Disease Revealed By Reliable Digital Memory Assessments

Alzheimer's Disease Revealed By Reliable Digital Memory Assessments Alzheimer's disease (AD) research has advanced in detecting pathological changes through biomarkers, but cognitive measures lag in capturing early, subtle impairments. Traditional assessments designed for overt deficits are now outpaced by discoveries in episodic memory networks within the medial temporal lobe, which are

Presyncope Patient Outcomes In Emergency Care

Presyncope Patient Outcomes In Emergency Care Overview Syncope is characterized by a transient loss of consciousness, whereas presyncope involves similar prodromal symptoms without the actual loss of consciousness. Although extensive research has examined the risk of serious outcomes in emergency department (ED) patients with syncope, the outcomes and management of patients with

Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient